The Clorox Company (NYSE:CLX) Receives $155.00 Consensus PT from Analysts

The Clorox Company (NYSE:CLX) has earned an average rating of “Reduce” from the fifteen research firms that are currently covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $155.00.

A number of equities analysts have recently commented on the company. Barclays boosted their price objective on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. DA Davidson raised their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. JPMorgan Chase & Co. lifted their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. Finally, Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st.

Insider Buying and Selling at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is owned by company insiders.

Hedge Funds Weigh In On Clorox

Hedge funds and other institutional investors have recently made changes to their positions in the stock. M&T Bank Corp lifted its position in Clorox by 0.9% during the 3rd quarter. M&T Bank Corp now owns 30,858 shares of the company’s stock worth $5,027,000 after acquiring an additional 287 shares during the period. Continuum Advisory LLC lifted its holdings in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Public Employees Retirement System of Ohio grew its position in Clorox by 26.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company’s stock valued at $9,736,000 after buying an additional 12,428 shares during the last quarter. Cape Cod Five Cents Savings Bank increased its stake in Clorox by 6.7% in the 3rd quarter. Cape Cod Five Cents Savings Bank now owns 20,366 shares of the company’s stock valued at $3,318,000 after buying an additional 1,275 shares during the period. Finally, Nomura Asset Management Co. Ltd. raised its position in Clorox by 10.8% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 333,839 shares of the company’s stock worth $54,386,000 after buying an additional 32,572 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 1.2 %

Shares of CLX stock opened at $167.69 on Wednesday. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $169.09. The company has a 50 day moving average price of $162.39 and a 200 day moving average price of $147.34. The stock has a market capitalization of $20.76 billion, a P/E ratio of 58.07, a price-to-earnings-growth ratio of 3.06 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 earnings per share. Equities research analysts predict that Clorox will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd were given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 2.91%. The ex-dividend date was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.